Toggle light / dark theme

MIT Makes Tissue – Such as Human Brain – Stretchable, Compressible, and Nearly Indestructible

Chemical process called ELAST allows labeling probes to infuse more quickly, and makes samples tough enough for repeated handling.

When there’s a vexing problem to be solved, people sometimes offer metaphorical advice such as “stretching the mind” or engaging in “flexible” thinking, but in confronting a problem facing many biomedical research labs, a team of MIT researchers has engineered a solution that is much more literal. To make imaging cells and molecules in brain and other large tissues easier while also making samples tough enough for years of handling in the lab, they have come up with a chemical process that makes tissue stretchable, compressible, and pretty much indestructible.

“ELAST” technology, described in a new paper in Nature Methods, provides scientists a very fast way to fluorescently label cells, proteins, genetic material, and other molecules within brains, kidneys, lungs, hearts, and other organs. That’s because when such tissues can be stretched out or squished down thin, labeling probes can infuse them far more rapidly. Several demonstrations in the paper show that even after repeated expansions or compressions to speed up labeling, tissues snap back to their original form unaltered except for the new labels.

Digitize your dog into a computer game

Researchers from the University of Bath have developed motion capture technology that enables you to digitize your dog without a motion capture suit and using only one camera.

The software could be used for a wide range of purposes, from helping vets diagnose lameness and monitoring recovery of their canine patients, to entertainment applications such as making it easier to put digital representations of into movies and video games.

Motion capture technology is widely used in the , where actors wear a suit dotted with white markers which are then precisely tracked in 3D space by multiple cameras taking images from different angles. Movement data can then be transferred onto a digital character for use in films or computer games.

Hadassah doctors crack the cause of fatal corona blood clots

A research team at Hadassah-University Medical Center in Jerusalem’s Ein Kerem has discovered what they believe causes coronavirus patients to become seriously ill and even die. They also say they have a way to treat the cause before it’s too late.

At least 30% of patients with coronavirus develop blood clots that block the flow of blood to their kidneys, heart and brain, as well as the lungs, according to international research.


Hadassah researchers discovered that the patients who form these fatal clots have an increased level of alpha defensin protein in their blood, explained Dr. Abd Alrauf Higavi, who directs a lab at Hadassah and has been studying blood clots for 30 years.

“Patients with mild symptoms have a low concentration of alpha defensin,” he said. “Patients with strong disease symptoms have high levels. The people who die have very high levels.”

The Hadassah team studied more than 700 blood samples from 80 patients who were admitted to the medical center during the first peak of the coronavirus outbreak in Israel. The results show that alpha defensin speeds up blood clot formation, which can cause pulmonary embolism, heart attacks and stroke. In addition, when blood clots form in the alveoli, whose function it is to exchange oxygen and carbon dioxide molecules to and from the bloodstream, this can lead to respiratory distress and eventually intubation.

Multiple studies have shown that around 80% of coronavirus patients who are intubated have died.

Advancing Automation in Digital Forensic Investigations Using Machine Learning Forensics

In the last few years, most of the data such as books, videos, pictures, medical and even the genetic information of humans are moving toward digital formats. Laptops, tablets, smartphones and wearable devices are the major source of this digital data transformation and are becoming the core part of our daily life. As a result of this transformation, we are becoming the soft target of various types of cybercrimes. Digital forensic investigation provides the way to recover lost or purposefully deleted or hidden files from a suspect’s device. However, current man power and government resources are not enough to investigate the cybercrimes. Unfortunately, existing digital investigation procedures and practices require huge interaction with humans; as a result it slows down the process with the pace digital crimes are committed. Machine learning (ML) is the branch of science that has governs from the field of AI. This advance technology uses the explicit programming to depict the human-like behaviour. Machine learning combined with automation in digital investigation process at different stages of investigation has significant potential to aid digital investigators. This chapter aims at providing the research in machine learning-based digital forensic investigation, identifies the gaps, addresses the challenges and open issues in this field.

Boston Dynamics will now sell any business its own Spot robot for $74,500

Robotmaker Boston Dynamics has finally put its four-legged robot Spot on general sale. After years of development, the company began leasing the machine to businesses last year, and, as of today, is now letting any US firm buy their very own Spot for $74,500.

It’s a hefty price tag, equal to the base price for a luxury Tesla Model S. But Boston Dynamics says, for that money, you’re getting the most advanced mobile robot in the world, able to go pretty much anywhere a human can (as long as there are no ladders involved).

Although Spot is certainly nimble, its workload is mostly limited right now to surveying and data collection. Trial deployments have seen Spot create 3D maps of construction sites and hunt for machine faults in offshore oil rigs. Less routine tests include helping hospitals triage COVID-19 patients and, somewhat controversially, working with a police bomb squad.

Scientists hail dexamethasone as ‘major breakthrough’ in treating coronavirus

Dexamethasone, a cheap and widely used steroid, has become the first drug shown to be able to save lives among Covid-19 patients in what scientists hailed as a “major breakthrough”.

Results of trials announced on Tuesday showed dexamethasone, which is used to reduce inflammation in other diseases, reduced death rates by around a third among the most severely ill Covid-19 patients admitted to hospital.

The results suggest the drug should immediately become standard care in patients with severe cases of the pandemic disease, said the researchers who led the trials.

Under-20s half as likely to contract coronavirus: study

If only we had working longevity/aging reversal science now.


People under the age of 20 are half as likely to contract COVID-19 than the rest of the population, according to new modeling released on Tuesday that suggests four out of five infected young people show no symptoms.

The research, published in the Nature Medicine Journal, could help inform the next moves of governments under pressure to reopen schools and colleges shuttered since the start of the pandemic.

Experts from the London School of Hygiene and Tropical Medicine developed age-based COVID-19 transmission models based on data from six countries—China, Italy, Japan, Singapore, Canada and South Korea.

Researchers: Cheap drug improves COVID-19 survival

Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid reduced deaths by up to one third in severely ill hospitalized patients.

The results were announced Tuesday and the British government immediately authorized the drug’s use across the United Kingdom for coronavirus patients like those who did well in the study. Researchers said they would publish results soon, and several independent experts said it’s important to see details to know how much of a difference the drug, dexamethasone, might make and for whom.

But “bottom line is, good news,” said the United States’ top infectious disease expert, Dr. Anthony Fauci. “This is a significant improvement in the available therapeutic options that we have.”

Study shows low socioeconomic status people experience more declines in age-related functions

A pair of researchers at University College London has found that people with low socioeconomic status experience more declines in age-related functions as they grow older than do people who have a higher socioeconomic status. In their paper published in Proceedings of the National Academy of Sciences, Andrew Steptoe and Paola Zaninotto describe their study of data from the English Longitudinal Study of Ageing, and what they learned.

Prior research has shown that tend to suffer more adverse health effects than those who are better off. They also tend to die younger. But one area of aging that has not been well-studied is the impact of poverty on age-related functional decline, associated with such symptoms as loss of hearing or muscle strength. To learn more about the relationship between socioeconomic status and age-related functional decline, the researchers analyzed data in the English Longitudinal Study of Ageing—an ongoing long-term study of the aging process. Launched in 2002, the study involved collecting data on volunteers aged 50 and over as they grew older. The data includes both medical and physical information, along with test results designed to measure cognitive and emotional levels. The data sample for this new effort included information on 5,018 people 52 years of age or older as they aged over periods of six to eight years.

The researchers found that people living at the lower end of the economic spectrum performed worse on every measure of age-related functionality. Those less well-off lost grip strength, lung function, gait speed, processing speed and executive function. They also tended to report enjoying life less than those who were more affluent. The researchers noted their findings were independent of race, gender, education or age. They also found that those of lesser means experienced more and were more likely to be depressed.

Here’s what potential Mars colonists really need from Earth: A large gene pool

Sending a handful of people certainly could serve as a proof of concept analogous to America’s Spanish and Portuguese outposts in the early 1500’s, or the English and Dutch settlements in the early 1600’s. In these instances the populations measured in the dozens and would not have amounted to a lasting European presence had they not been followed by thousands of new settlers over the next few decades. But, given our more advanced technology, our level of medicine, the idea that humans could have equipment that will utilize the Martian environment to produce food, air, and other consumables, and the certainty that settlers will not be at war with the Martian equivalent of the Aztecs or Incas—couldn’t a Martian settlement survive long term with just a low number of colonists?

The answer is no—not if the goal is a permanent human presence. Not if the goal is to provide our species with some kind of extinction insurance against planetary disaster on Earth, such as a mega-volcanic eruption, nuclear war, or some other existential threat. Mars setters can use technology to get air and food from the Mars environment, but early European explorers in the New World had access to one natural resource that mid-21st century Mars colonists will not be able to manufacture: a human gene pool.

If we really want Martian colonies, we can’t send just a few Adams and Eves. We can’t set-up a Martian Jamestown of 100 people. Long-term survival will depend on the genetic diversity of a large gene pool, and this means the Elon Musk plan of sending thousands might be the only colonization plan that could work.